Early access
Sign in
Taking people in United StatesNo phase

Comparing Personalized Nutrition Guided by Glucose Monitors in Type 2 Diabetes

Tests nutrition advice personalized with continuous glucose monitor feedback in adults with type 2 diabetes.

Key facts

Who runs it
University of Minnesota
Where
Minneapolis, United StatesSee the site
Trial code
Registry title
Individualized Diabetes Education Assisted by CGM (IDEA-CGM)
Status
Recruiting
People taking part
72 people, planned
Started
14 Jul 2025
Expected to end
15 Sept 2027
Type of study
Interventional, 4 groups
Treatments tested
  • Unblinded CGM/Nutrition Therapy
  • Blinded CGM/Nutrition Therapy
  • Unblinded CGM/No Nutrition Therapy
  • Blinded CGM/No Nutrition Therapy
Record updated
16 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes and a blood sugar marker (HbA1c) between 6.8-8.5% (51–69 mmol/mol). It tests nutrition advice guided by a glucose monitor.

Age
18 years or older
Sex
All sexes can join
Disease stage
Previous diagnosis of type 2 diabetes; HbA1c of 6.8-8.5% (51–69 mmol/mol)
Earlier treatment
Cannot be on insulin, sulfonylurea, or meglitinide. No change in glucose-lowering medicines or their dose in the 3 months before joining.
Biomarker or test result
HbA1c of 6.8-8.5% (51–69 mmol/mol)

Main reasons for not taking part

  • Type 1 diabetes
  • Treatment with insulin, sulfonylurea, or meglitinide
  • Medicines that affect blood sugar, such as corticosteroids
  • BMI under 25 kg/m2 (under 23 kg/m2 for people who self-identify as Asian)
  • Pregnancy, plans to become pregnant soon, or breastfeeding

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • at least 18 years of age
  • previous diagnosis of T2DM
  • HbA1c of 6.8-8.5%

Who cannot take part

  • treatment with insulin, sulfonylurea, or meglitinide
  • weight change >5 pounds in the 3 months prior to study enrollment
  • type 1 diabetes mellitus
  • use of nondiabetic medications that affect blood glucose control (such as corticosteroids)
  • pregnancy or immediate plans to become pregnant 8) breastfeeding 9) anemia (which would affect measurement of HbA1c) 10) changes to glucose lowering medications, including change in dose, in the 3 months prior to enrollment 11) presence of any disease that would make adherence to the protocol difficult."
  • BMI <25 kg/m2 or <23 kg/m2 for participants who self-identify as Asian
  • estimated glomerular filtration rate <60 ml/minute/1.73 m2

Where in United States

  • University of MinnesotaMinneapolis, United StatesContact: Anne BantleTaking people

About the trial

What the trial wants to find out

This project will compare medical nutrition therapy personalized by continuous glucose monitor (CGM) feedback to control interventions in participants with type 2 diabetes mellitus (T2DM).

The 4 groups in the trial

  • Unblinded CGM/Nutrition TherapyTreatment being tested
  • Blinded CGM/Nutrition TherapyTreatment being tested
  • Unblinded CGM/No Nutrition TherapyTreatment being tested
  • Blinded CGM/No Nutrition TherapyTreatment being tested

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Individualized Diabetes Education Assisted by CGM (IDEA-CGM)
Plain-language title
Comparing Personalized Nutrition Guided by Glucose Monitors in Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
16 July 2026